IBDEI1F6 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,22962,1,3,0)
;;=3^Atopic Dermatitis
;;^UTILITY(U,$J,358.3,22962,1,4,0)
;;=4^L20.89
;;^UTILITY(U,$J,358.3,22962,2)
;;=^5009112
;;^UTILITY(U,$J,358.3,22963,0)
;;=L25.9^^76^992^15
;;^UTILITY(U,$J,358.3,22963,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22963,1,3,0)
;;=3^Contact Dermatitis,Unspec
;;^UTILITY(U,$J,358.3,22963,1,4,0)
;;=4^L25.9
;;^UTILITY(U,$J,358.3,22963,2)
;;=^5133647
;;^UTILITY(U,$J,358.3,22964,0)
;;=L40.0^^76^992^16
;;^UTILITY(U,$J,358.3,22964,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22964,1,3,0)
;;=3^Psoriasis
;;^UTILITY(U,$J,358.3,22964,1,4,0)
;;=4^L40.0
;;^UTILITY(U,$J,358.3,22964,2)
;;=^5009160
;;^UTILITY(U,$J,358.3,22965,0)
;;=L29.9^^76^992^17
;;^UTILITY(U,$J,358.3,22965,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22965,1,3,0)
;;=3^Pruritus
;;^UTILITY(U,$J,358.3,22965,1,4,0)
;;=4^L29.9
;;^UTILITY(U,$J,358.3,22965,2)
;;=^5009153
;;^UTILITY(U,$J,358.3,22966,0)
;;=L85.3^^76^992^18
;;^UTILITY(U,$J,358.3,22966,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22966,1,3,0)
;;=3^Xerosis
;;^UTILITY(U,$J,358.3,22966,1,4,0)
;;=4^L85.3
;;^UTILITY(U,$J,358.3,22966,2)
;;=^5009323
;;^UTILITY(U,$J,358.3,22967,0)
;;=L30.2^^76^992^19
;;^UTILITY(U,$J,358.3,22967,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22967,1,3,0)
;;=3^Cutaneous Autosensitization/ld
;;^UTILITY(U,$J,358.3,22967,1,4,0)
;;=4^L30.2
;;^UTILITY(U,$J,358.3,22967,2)
;;=^5009155
;;^UTILITY(U,$J,358.3,22968,0)
;;=L72.0^^76^992^20
;;^UTILITY(U,$J,358.3,22968,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22968,1,3,0)
;;=3^Epidermal Cyst
;;^UTILITY(U,$J,358.3,22968,1,4,0)
;;=4^L72.0
;;^UTILITY(U,$J,358.3,22968,2)
;;=^5009277
;;^UTILITY(U,$J,358.3,22969,0)
;;=L73.9^^76^992^21
;;^UTILITY(U,$J,358.3,22969,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22969,1,3,0)
;;=3^Follicular Disorder/Folliculitis
;;^UTILITY(U,$J,358.3,22969,1,4,0)
;;=4^L73.9
;;^UTILITY(U,$J,358.3,22969,2)
;;=^5009286
;;^UTILITY(U,$J,358.3,22970,0)
;;=L70.0^^76^992^22
;;^UTILITY(U,$J,358.3,22970,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22970,1,3,0)
;;=3^Acne
;;^UTILITY(U,$J,358.3,22970,1,4,0)
;;=4^L70.0
;;^UTILITY(U,$J,358.3,22970,2)
;;=^5009268
;;^UTILITY(U,$J,358.3,22971,0)
;;=L71.8^^76^992^23
;;^UTILITY(U,$J,358.3,22971,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22971,1,3,0)
;;=3^Rosacea
;;^UTILITY(U,$J,358.3,22971,1,4,0)
;;=4^L71.8
;;^UTILITY(U,$J,358.3,22971,2)
;;=^5009275
;;^UTILITY(U,$J,358.3,22972,0)
;;=L91.0^^76^992^24
;;^UTILITY(U,$J,358.3,22972,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22972,1,3,0)
;;=3^Hypertrophic Scar
;;^UTILITY(U,$J,358.3,22972,1,4,0)
;;=4^L91.0
;;^UTILITY(U,$J,358.3,22972,2)
;;=^5009459
;;^UTILITY(U,$J,358.3,22973,0)
;;=L91.8^^76^992^25
;;^UTILITY(U,$J,358.3,22973,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22973,1,3,0)
;;=3^Skin Tag/Oth Hypertrophic Disorder of Skin
;;^UTILITY(U,$J,358.3,22973,1,4,0)
;;=4^L91.8
;;^UTILITY(U,$J,358.3,22973,2)
;;=^5009460
;;^UTILITY(U,$J,358.3,22974,0)
;;=I87.2^^76^992^26
;;^UTILITY(U,$J,358.3,22974,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22974,1,3,0)
;;=3^Stasis Dermatitis/Venous Insufficiency
;;^UTILITY(U,$J,358.3,22974,1,4,0)
;;=4^I87.2
;;^UTILITY(U,$J,358.3,22974,2)
;;=^5008047
;;^UTILITY(U,$J,358.3,22975,0)
;;=D69.8^^76^992^27
;;^UTILITY(U,$J,358.3,22975,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1F6 3770 printed Sep 23, 2025@19:43:32 Page 2
IBDEI1F6 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,22962,1,3,0)
+2 ;;=3^Atopic Dermatitis
+3 ;;^UTILITY(U,$J,358.3,22962,1,4,0)
+4 ;;=4^L20.89
+5 ;;^UTILITY(U,$J,358.3,22962,2)
+6 ;;=^5009112
+7 ;;^UTILITY(U,$J,358.3,22963,0)
+8 ;;=L25.9^^76^992^15
+9 ;;^UTILITY(U,$J,358.3,22963,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,22963,1,3,0)
+12 ;;=3^Contact Dermatitis,Unspec
+13 ;;^UTILITY(U,$J,358.3,22963,1,4,0)
+14 ;;=4^L25.9
+15 ;;^UTILITY(U,$J,358.3,22963,2)
+16 ;;=^5133647
+17 ;;^UTILITY(U,$J,358.3,22964,0)
+18 ;;=L40.0^^76^992^16
+19 ;;^UTILITY(U,$J,358.3,22964,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,22964,1,3,0)
+22 ;;=3^Psoriasis
+23 ;;^UTILITY(U,$J,358.3,22964,1,4,0)
+24 ;;=4^L40.0
+25 ;;^UTILITY(U,$J,358.3,22964,2)
+26 ;;=^5009160
+27 ;;^UTILITY(U,$J,358.3,22965,0)
+28 ;;=L29.9^^76^992^17
+29 ;;^UTILITY(U,$J,358.3,22965,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,22965,1,3,0)
+32 ;;=3^Pruritus
+33 ;;^UTILITY(U,$J,358.3,22965,1,4,0)
+34 ;;=4^L29.9
+35 ;;^UTILITY(U,$J,358.3,22965,2)
+36 ;;=^5009153
+37 ;;^UTILITY(U,$J,358.3,22966,0)
+38 ;;=L85.3^^76^992^18
+39 ;;^UTILITY(U,$J,358.3,22966,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,22966,1,3,0)
+42 ;;=3^Xerosis
+43 ;;^UTILITY(U,$J,358.3,22966,1,4,0)
+44 ;;=4^L85.3
+45 ;;^UTILITY(U,$J,358.3,22966,2)
+46 ;;=^5009323
+47 ;;^UTILITY(U,$J,358.3,22967,0)
+48 ;;=L30.2^^76^992^19
+49 ;;^UTILITY(U,$J,358.3,22967,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,22967,1,3,0)
+52 ;;=3^Cutaneous Autosensitization/ld
+53 ;;^UTILITY(U,$J,358.3,22967,1,4,0)
+54 ;;=4^L30.2
+55 ;;^UTILITY(U,$J,358.3,22967,2)
+56 ;;=^5009155
+57 ;;^UTILITY(U,$J,358.3,22968,0)
+58 ;;=L72.0^^76^992^20
+59 ;;^UTILITY(U,$J,358.3,22968,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,22968,1,3,0)
+62 ;;=3^Epidermal Cyst
+63 ;;^UTILITY(U,$J,358.3,22968,1,4,0)
+64 ;;=4^L72.0
+65 ;;^UTILITY(U,$J,358.3,22968,2)
+66 ;;=^5009277
+67 ;;^UTILITY(U,$J,358.3,22969,0)
+68 ;;=L73.9^^76^992^21
+69 ;;^UTILITY(U,$J,358.3,22969,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,22969,1,3,0)
+72 ;;=3^Follicular Disorder/Folliculitis
+73 ;;^UTILITY(U,$J,358.3,22969,1,4,0)
+74 ;;=4^L73.9
+75 ;;^UTILITY(U,$J,358.3,22969,2)
+76 ;;=^5009286
+77 ;;^UTILITY(U,$J,358.3,22970,0)
+78 ;;=L70.0^^76^992^22
+79 ;;^UTILITY(U,$J,358.3,22970,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,22970,1,3,0)
+82 ;;=3^Acne
+83 ;;^UTILITY(U,$J,358.3,22970,1,4,0)
+84 ;;=4^L70.0
+85 ;;^UTILITY(U,$J,358.3,22970,2)
+86 ;;=^5009268
+87 ;;^UTILITY(U,$J,358.3,22971,0)
+88 ;;=L71.8^^76^992^23
+89 ;;^UTILITY(U,$J,358.3,22971,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,22971,1,3,0)
+92 ;;=3^Rosacea
+93 ;;^UTILITY(U,$J,358.3,22971,1,4,0)
+94 ;;=4^L71.8
+95 ;;^UTILITY(U,$J,358.3,22971,2)
+96 ;;=^5009275
+97 ;;^UTILITY(U,$J,358.3,22972,0)
+98 ;;=L91.0^^76^992^24
+99 ;;^UTILITY(U,$J,358.3,22972,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,22972,1,3,0)
+102 ;;=3^Hypertrophic Scar
+103 ;;^UTILITY(U,$J,358.3,22972,1,4,0)
+104 ;;=4^L91.0
+105 ;;^UTILITY(U,$J,358.3,22972,2)
+106 ;;=^5009459
+107 ;;^UTILITY(U,$J,358.3,22973,0)
+108 ;;=L91.8^^76^992^25
+109 ;;^UTILITY(U,$J,358.3,22973,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,22973,1,3,0)
+112 ;;=3^Skin Tag/Oth Hypertrophic Disorder of Skin
+113 ;;^UTILITY(U,$J,358.3,22973,1,4,0)
+114 ;;=4^L91.8
+115 ;;^UTILITY(U,$J,358.3,22973,2)
+116 ;;=^5009460
+117 ;;^UTILITY(U,$J,358.3,22974,0)
+118 ;;=I87.2^^76^992^26
+119 ;;^UTILITY(U,$J,358.3,22974,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,22974,1,3,0)
+122 ;;=3^Stasis Dermatitis/Venous Insufficiency
+123 ;;^UTILITY(U,$J,358.3,22974,1,4,0)
+124 ;;=4^I87.2
+125 ;;^UTILITY(U,$J,358.3,22974,2)
+126 ;;=^5008047
+127 ;;^UTILITY(U,$J,358.3,22975,0)
+128 ;;=D69.8^^76^992^27
+129 ;;^UTILITY(U,$J,358.3,22975,1,0)
+130 ;;=^358.31IA^4^2
